8-K - Fulgent Genetics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. Purchase and Sale Agreement On December 20, 2025, Inform Diagnostics, Inc. (the “Buyer”), a wholly owned subsidiary

Material Agreement

$12.5M

Source Document

8.01

Other Events. On December 22, 2025, the Company and Consonance Capital Partners issued a joint press release announcing the execution of the PSA and APA. A copy

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1* Purchase and Sale Agreement, dated December 20, 2025, by and among Bako Pathology

Exhibits Only

Source Document

Exhibits (4)

10.1

EX-10.1

10.2

EX-10.2

8-K

99.1

EX-99.1